Kohno T, Moriuchi R, Katamine S, Yamada Y, Tomonaga M, Matsuyama T
Department of Molecular Microbiology and Immunology, Nagasaki University Graduate School of Medicine, Nagasaki 852-8523, Japan.
Jpn J Cancer Res. 2000 Nov;91(11):1103-10. doi: 10.1111/j.1349-7006.2000.tb00892.x.
Patients with adult T-cell leukemia/lymphoma (ATL) exhibit a variety of clinical features, and this disease is therefore clinically subclassified into acute, lymphomatous, chronic, and smoldering types. Acute ATL is a typical leukemic form of ATL with rapid progression, and chronic ATL is a less aggressive clinical form allowing long-term survival even without chemotherapy. In the present study, we used fresh peripheral blood mononuclear cells (PBMC) from both types of ATL patients to identify molecules that may contribute to the difference between acute and chronic ATL. Isolated mRNAs expressed differentially between the two types of ATL include a T-cell differentiation antigen (MAL), a lymphoid-specific member of the G-protein-coupled receptor family (EBI-1 / CCR7), a novel human homologue to a subunit (MNLL) of the bovine ubiquinone oxidoreductase complex, and a human fibrinogen-like protein (hpT49). We found that the former three are upregulated in acute ATL and the last is down-regulated in both chronic and acute ATL. We speculate that dysregulation of the genes may account for the malignant features of ATL cells, in terms of growth, energy metabolism, and motility.
成人T细胞白血病/淋巴瘤(ATL)患者表现出多种临床特征,因此该疾病在临床上被分为急性、淋巴瘤样、慢性和隐匿型。急性ATL是ATL的典型白血病形式,进展迅速,而慢性ATL是一种侵袭性较小的临床形式,即使不进行化疗也能长期存活。在本研究中,我们使用了这两种类型ATL患者的新鲜外周血单个核细胞(PBMC)来鉴定可能导致急性和慢性ATL差异的分子。在两种类型的ATL之间差异表达的分离mRNA包括一种T细胞分化抗原(MAL)、G蛋白偶联受体家族的淋巴特异性成员(EBI-1 / CCR7)、牛泛醌氧化还原酶复合物一个亚基(MNLL)的新型人类同源物以及一种人纤维蛋白原样蛋白(hpT49)。我们发现前三种在急性ATL中上调,最后一种在慢性和急性ATL中均下调。我们推测,这些基因的失调可能在生长、能量代谢和运动性方面解释了ATL细胞的恶性特征。